Pharmacokinetic profiles of artesunate following multiple intravenous doses of 2, 4, and 8 mg/kg in healthy volunteers: Phase 1b study

BACKGROUND: Severe malaria results in over a million deaths every year, most of them in children aged less than five years and living in sub-Saharan Africa. Injectable artesunate (AS) was recommended as initial treatment for severe malaria by WHO in 2006. The Walter Reed Army Institute of Research (...

Descripción completa

Detalles Bibliográficos
Autores principales: Miller, Robert Scott, Li, Qigui, Cantilena, Louis R, Leary, Kevin J, Saviolakis, George A, Melendez, Victor, Smith, Bryan, Weina, Peter J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3468400/
https://www.ncbi.nlm.nih.gov/pubmed/22853818
http://dx.doi.org/10.1186/1475-2875-11-255

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3468400/
https://www.ncbi.nlm.nih.gov/pubmed/22853818
http://dx.doi.org/10.1186/1475-2875-11-255

Ejemplares similares